In this Opinion article, Twumasi-Boateng et al. discuss the use of oncolytic viruses as multiplexed immune-modulating platforms with the potential to improve the effectiveness of immunotherapies through novel synergistic mechanisms promoting antitumour immune activity.
- Kwame Twumasi-Boateng
- Jessica L. Pettigrew
- Brad H. Nelson